ArticleCureus2025
A Double-Edged Sword: The Clinical Dilemma of Lupus Nephritis and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lupus nephritis (LN) and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are classically regarded as distinct autoimmune diseases with differing pathophysiologic mechanisms-immune complex-mediated injury in LN versus pauci-immune necrotizing vasculitis in AAV. However, recent studies have identified a rare but emerging overlap syndrome characterized by dual serologic, histopathologic, and clinical features. This diagnostic entity presents unique challenges, particularly in older adults with rapidly progressive glomerulonephritis (RPGN) and systemic inflammation. We describe a diagnostically challenging case of a 74-year-old woman with a history of interstitial lung disease, polyarthritis, and sicca symptoms who developed new-onset hemoptysis, peripheral neuropathy, and acute kidney injury. She underwent an extensive workup, which revealed hypocomplementemia, high-titer antinuclear antibody (ANA), and seropositivity for Sjögren's-syndrome-related antigen A (SSA/Ro) and ribonucleoprotein (RNP) antibodies, along with markedly elevated myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) levels. These findings raised concern for dual autoimmune pathology. Laboratory evaluation additionally demonstrated worsening kidney function, proteinuria, and microscopic hematuria, prompting a renal biopsy. Histologic examination revealed class IV LN, characterized by diffuse immune complex deposition, as well as necrotizing crescentic glomerulonephritis, a hallmark of pauci-immune AAV. These overlapping serologic and histopathologic features, in the context of pulmonary hemorrhage, were diagnostic of LN-AAV overlap syndrome. The patient was treated with aggressive immunosuppressive therapy, resulting in improvement of renal function and resolution of systemic symptoms. This case underscores the importance of maintaining a high index of suspicion for overlapping autoimmune phenomena in elderly patients with atypical serologic and histopathologic findings. Early recognition is essential to initiate appropriate therapy and improve outcomes in this complex clinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.